Non-Deal Roadshows – Institutional and Private Wealth
Meirav brings over 11 years of Investor Relations experience, advising local, dual, and international listed Israeli public companies across industries, with expertise in Life Sciences and Bio-tech companies.
Previously, she was a Senior Account Executive at KM Investor Relations, Israel’s first and leading IR firm.
In the life-science industry, Meirav has advised companies like BioLineRx, Compugen, Exalenz, Check-Cap, Alcobra, BioBlast, Medigus, Therapix Biosciences, and others, creating, executing and maintaining their IR and Financial media strategy and relationships with the Israeli capital market and financial media. This also included targeting and NDR’s, advisory services related to public and private securities offerings, and crisis management. In her position as a Senior Account Executive at KM Investor Relations, Meirav has formed and managed a first-time designated Family Office and HNW forum specializing in HNW activity and events. Working closely with the Israeli Capital market, Meirav has long-term relationships with Institutional investors, Strategic investors; Private Equity and Hedge funds, Proprietary traders as well as Family Offices and HNW individuals. Meirav holds a Bachelor of Laws (LL.B) from Tel Aviv University and a Master of Business Administration (MBA) from Bar Ilan University in Israel.